| Financial Year |
March 31 2023 |
| Monetary Funds |
2,309,816,463.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,151,837,456.88 |
| Advances to Suppliers |
390,863,650.12 |
| Other Receivables |
26,038,402.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,190,329,472.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
90,609,634.53 |
| Total Current Assets |
5,827,528,708.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,504,853,762.64 |
| Investment Properties |
-- |
| Fixed Assetes |
6,462,331,430.16 |
| Under-construction Projects |
859,049,304.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,725,547,370.42 |
| R&D expenses |
141,509.43 |
| Goodwill |
84,229,696.23 |
| Long-Term Deferred and Prepaid Expenses |
419,479,547.10 |
| Deferred Income Tax Assets |
51,076,048.93 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
13,110,719,761.76 |
| Total Assets |
18,938,248,470.04 |
| Short-Term Loans |
1,419,643,228.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
320,924,606.43 |
| Accounts Payable |
1,092,906,481.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,789,691.27 |
| Taxes Payable |
53,926,325.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
473,621,923.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,029,741,995.72 |
| Other Current Liabilities |
54,514,676.49 |
| Sub-Total of Current Liabilities |
4,887,545,715.47 |
| Long-term Loans |
1,466,503,258.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
462,185,893.10 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
150,016,644.30 |
| Sub-Total of Non-Current Liabilities |
2,097,900,391.48 |
| Total Liabilities |
6,985,446,106.95 |
| Paid-In Capital(Or Share Stock) |
3,886,261,065.00 |
| Capital Surplus |
5,004,046,635.18 |
| Surplus Reserve |
332,853,103.30 |
| LESS:Treasury Stock |
199,865,999.04 |
| Undistributed Profits |
1,348,367,089.54 |
| Minority Stockholder's Interest |
1,550,010,551.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,402,791,811.79 |
| Owner's Equity（Stockholder's Equity） |
11,952,802,363.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,938,248,470.04 |
